Edition:
India

GNC Holdings Inc (GNC.N)

GNC.N on New York Stock Exchange

3.71USD
23 Apr 2018
Change (% chg)

$-0.07 (-1.85%)
Prev Close
$3.78
Open
$3.80
Day's High
$3.80
Day's Low
$3.67
Volume
266,063
Avg. Vol
862,434
52-wk High
$10.95
52-wk Low
$3.13

Select another date:

Thu, Apr 5 2018

BRIEF-GNC Announces Plans To Expand Into Australia

* GENERAL NUTRITION CORPORATION ANNOUNCED PLANS TO ESTABLISH, DEVELOP PRESENCE IN AUSTRALIAN MARKET

BRIEF-GNC Holdings ‍Expects To Increase To Over 4,000 Retail Outlets Across India By 2020​

* GNC HOLDINGS INC - ‍EXPECTED TO INCREASE TO OVER 4,000 RETAIL OUTLETS ACROSS INDIA BY 2020​

GNC tweaks maturity extension amendment to thwart holdouts

NEW YORK, Feb 21 (LPC) - Ailing US vitamin and supplement retailer GNC Holdings Inc has sweetened the terms of a complex amendment to its existing credit agreement to extend a looming March 2019 debt maturity, after early consents from lenders fell short of a required threshold, according to three sources familiar with the transaction.

BRIEF-Harbin Pharma Scraps Plan For Unit To Bid For GNC's China Business

* SAYS CONTROLLING SHAREHOLDER SIGNS AGREEMENT TO BUY GNC HOLDINGS' CONVERTIBLE PREFERENCE SHARES WORTH $299.95 MILLION

China's Harbin Pharma to buy stake in U.S. health retailer GNC

HONG KONG China's state-controlled drugmaker Harbin Pharmaceutical Group Holding Co will buy an about 40 percent stake in U.S. nutritional supplements retailer GNC Holdings Inc for $300 million and are in talks for a joint venture in China, the companies said.

China's Harbin Pharma to buy stake in U.S. health retailer GNC

HONG KONG, Feb 14 China's state-controlled drugmaker Harbin Pharmaceutical Group Holding Co will buy an about 40 percent stake in U.S. nutritional supplements retailer GNC Holdings Inc for $300 million and are in talks for a joint venture in China, the companies said.

BRIEF-GNC Holdings Says Launched Certain Amendments To Credit Agreement

* GNC HOLDINGS SAYS LAUNCHED CERTAIN AMENDMENTS TO CREDIT AGREEMENT DATED AS OF NOV 26, 2013​ - SEC FILING

BRIEF-GNC Holdings Says On Deal Termination Co to Pay Termination Fee Of Either $10 Mln Or $18 Mln To Harbin Pharmaceutical

* GNC HOLDINGS - ON DEAL TERMINATION UNDER CIRCUMSTANCES, CO WILL PAY FEE OF EITHER $10 MILLION OR $18 MILLION TO HARBIN PHARMACEUTICAL GROUP - SEC FILING Source text: (http://bit.ly/2o4g6KY) Further company coverage:

BRIEF-GNC And Harbin Pharmaceutical Announce $300 Mln Strategic Investment

* GNC AND HARBIN PHARMACEUTICAL ANNOUNCE $300 MILLION STRATEGIC INVESTMENT AND CHINA JOINT VENTURE

BRIEF-GNC Holdings Q4 Loss Per Share $2.99

* GNC HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS

Select another date: